Doxycycline

Mechanism

Both drugs can cause benign intracranial hypertension (pseudotumor cerebri). Some cases on isotretinoin occurred with concomitant tetracyclines (isotretinoin SmPC), and permanent vision loss has been reported with tetracyclines, including doxycycline (doxycycline SmPC). The risks add up when the drugs are combined.

Symptoms

Headache, nausea, vomiting, visual disturbances; papilloedema on fundoscopy (isotretinoin SmPC). Intracranial pressure can stay raised for weeks after the drug is stopped (doxycycline SmPC).

Management

The combination is contraindicated: the Spanish isotretinoin SmPC contraindicates isotretinoin with tetracyclines, which include doxycycline (isotretinoin SmPC). The doxycycline SmPC and the US isotretinoin label both say the combination must be avoided (doxycycline SmPC; US isotretinoin label). If an antibiotic is needed during isotretinoin treatment, tetracyclines are not chosen. If headache, nausea, vomiting, visual disturbances or papilloedema appear, stop isotretinoin at once (isotretinoin SmPC) and refer the patient to a neurologist (US isotretinoin label); visual symptoms need an urgent eye examination (doxycycline SmPC). Intracranial pressure can stay raised for weeks after stopping, so follow the patient until it stabilises (doxycycline SmPC).

Mechanism

The doxycycline label states that tetracycline absorption is reduced by antacids or other drugs containing divalent or trivalent cations such as calcium, magnesium or iron, and advises spacing by 2 to 3 hours. Doxycycline is often prescribed in long courses for acne or rosacea, exactly when calcium is taken daily.

Symptoms

Acne or rosacea fails to improve after 6–8 weeks of correct treatment, and the dose gets raised when the problem is the timing.

Management

Space by 2–3 hours. Doxycycline is taken with plenty of water and without lying down afterwards because of oesophagitis risk, which fits a midday dose; calcium then goes with dinner.

Mechanism

Carbamazepine induces CYP3A4 and accelerates hepatic doxycycline metabolism. Doxycycline half-life shortens from 16 to 7 hours; plasma levels fall.

Symptoms

The patient feels nothing. Risk of subtherapeutic antimicrobial concentrations and treatment failure rises – particularly with pathogens at the susceptibility breakpoint.

Management

Increase doxycycline to 200 mg twice daily during the course (instead of standard 100 mg twice daily). Alternative antibiotics without induction-driven loss: a cephalosporin, amoxicillin, azithromycin. Alternative anticonvulsants without induction: levetiracetam, lamotrigine.

Mechanism

Iron is named in the label alongside calcium and magnesium as a cation that reduces tetracycline absorption. The binding works both ways: the iron that gets absorbed also drops, so neither the antibiotic nor the anaemia treatment performs as planned.

Symptoms

An antibiotic course without the expected response and, in parallel, ferritin that fails to rise at the 4–8 week check.

Management

At least 2–3 hours apart. For short courses the practical arrangement is iron with dinner and doxycycline in the morning. If the course is long, repeat ferritin at the end to confirm the iron treatment is making progress.

Mechanism

A bacteriostatic agent (doxycycline) suppresses the bactericidal action of a beta-lactam (amoxicillin), which requires active bacterial division. Antibacterial efficacy drops.

Symptoms

Persistent fever, infection symptoms, and inflammation markers 48–72 hours after starting therapy. Resistant strain selection possible.

Management

Avoid the combination — choose a single antibiotic based on pathogen and infection site. For mixed infections (e.g. aspiration pneumonia), prefer switching to amoxicillin-clavulanate (broader spectrum) or a cephalosporin with metronidazole. For Lyme disease, use doxycycline monotherapy; for respiratory infections with confirmed sensitivity, amoxicillin.

Mechanism

The doxycycline and itraconazole labels do not mention each other and describe no shared interaction mechanism. Itraconazole is a strong inhibitor of the CYP3A4 enzyme, but doxycycline is not cleared through it: only hepatic enzyme inducers (carbamazepine, phenytoin, barbiturates, rifampicin, chronic alcohol use) speed up its metabolism, and it is excreted through the gut and the kidney. The only common ground is the liver. Both drugs are potentially hepatotoxic: itraconazole has very rare reports of serious hepatotoxicity, including fatal acute liver failure, mostly in patients with pre-existing liver disease or taking other hepatotoxic drugs, and the doxycycline label asks for caution with potentially hepatotoxic drugs.

Symptoms

The documents expect no change in the concentration of either drug and describe no added adverse effects from an interaction. The liver is what to watch: loss of appetite, nausea, vomiting, fatigue, abdominal pain or dark urine are signs of hepatitis that the itraconazole label asks patients to report at once. During long doxycycline courses, liver tests, blood counts and kidney function are checked as well.

Management

The combination is acceptable and doses stay unchanged: neither the doxycycline label nor the itraconazole label (AEMPS and FDA) names this pair. Caution concerns the liver. Potentially hepatotoxic drugs are used with caution in patients taking doxycycline (doxycycline label, 4.5), and liver function monitoring is considered in patients taking itraconazole, above all with prior liver disease or hepatotoxicity from other drugs (itraconazole label, 4.4). Patients are told to report signs of hepatitis right away: loss of appetite, nausea, vomiting, fatigue, abdominal pain or dark urine (itraconazole label, 4.4). On long doxycycline courses, blood counts and kidney and liver function are checked periodically (doxycycline label, 4.4; FDA doxycycline label, 5.11).

Mechanism

Magnesium shares the list with calcium and iron in the doxycycline label. Beyond the supplement, the warning covers magnesium antacids, which patients tend to take precisely for the stomach upset the antibiotic causes.

Symptoms

Reduced course efficacy with no warning signs. The loop closes on itself: the antibiotic causes heartburn, the antacid lowers the antibiotic.

Management

Space by 2–3 hours. For doxycycline's stomach upset, taking it with food and plenty of water works better than adding a magnesium or aluminium antacid.

Mechanism

NIH ODS names tetracycline antibiotics among those that interact with zinc. The binding reduces absorption of both. The combination is routine in dermatology: zinc is taken for acne and doxycycline is prescribed for the same thing.

Symptoms

Acne treatment that stalls despite good adherence.

Management

Spacing by 2–3 hours is enough. In dermatology practice zinc goes with dinner and doxycycline with breakfast or lunch.

Mechanism

Doxycycline forms non-absorbable chelates with calcium in the gut (and with other polyvalent cations — magnesium, iron, aluminium). Doxycycline bioavailability falls by 50–80%.

Symptoms

Persistent infection symptoms 48–72 hours after antibiotic start, risk of clinical failure.

Management

Take doxycycline 2 hours before or 6 hours after calcium carbonate. Apply the same interval for iron, magnesium, zinc, and aluminium-containing antacids. If timing separation is impossible, choose an alternative antibiotic (amoxicillin, a cephalosporin).

Mechanism

Doxycycline does not induce CYP3A4 and does not affect oestradiol metabolism. No clinically significant reduction in menopausal hormone therapy efficacy has been reported.

Symptoms

The combination usually causes no specific symptoms. Each drug's individual side effects remain.

Management

No dose adjustment needed. In women on menopausal hormone therapy, doxycycline is used without special precautions for infections requiring it.

Mechanism

Doxycycline does not affect hepatic ethinylestradiol metabolism. The historical theory of reduced COC efficacy via suppression of enterohepatic recirculation is rejected by meta-analyses.

Symptoms

The combination usually causes no specific symptoms. Each drug's individual side effects remain.

Management

Additional contraception during short doxycycline courses is not needed. For long-term therapy (e.g. acne, Lyme disease), no adjustment either.